Healthy subjects
Conditions
Interventions
Subjects receive a single dose of fat-soluble vitamins + water. After the washout period (13 days or more), subjects receive a single dose of fat-soluble vitamins + fermented milk.
Subjects receive a
Sponsors
Meiji Co., Ltd.
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1) Subjects giving written informed consent 2) Males aged 20 to 35 years old when consent acquisition 3) Subjects whose body mass index (BMI) is from 18.5 kg/m2 to 25.0 kg/m2
Exclusion criteria
Exclusion criteria: 1) Subjects who routinely use pharmaceuticals, quasi-drugs, dietary supplement, and consume food for specified health uses, supplements containing fat-soluble vitamins more than two days per week 2) Subjects who have chronic diseases necessitating treatments and/or medications 3) Subjects who have abnormal lipid metabolism, glucose metabolism, liver function, or kidney function 4) Subjects who received digestive surgical procedures 5) habitual smokers 6) Subjects who participate in other clinical trials within the past month or have plans to participate in other clinical trials during this study period 7) Subjects who have food allergy 8) Subjects who is conscious of being prone to diarrhea from dairy products 9) Subjects who donate 200 mL of blood within a month, or 400 mL of blood within three month 10) Subjects who determine ineligible by the principal investigator or sub-investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Plasma fat-soluble vitamins and their metabolites concentrations Plasma GLP-2 concentrations | — |
Countries
Japan
Contacts
Public ContactMasashi Morifuji
Meiji Co., Ltd. Food Microbiology and Function Research Laboratories, R&D Division
Outcome results
None listed